Avalo Therapeutics, Inc. ($AVTX)
Filing Information
| Accession Number | 0001918845-26-000014 |
|---|---|
| Form Type | 4 |
| Filing Date | May 26, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
43,500
Total Value
$0.00
P&L
+inf% (+$850,425.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | May 21, 2026 | Grant/Award | 43,500 | $0.00 | $0.00 | 47,122 | Direct | โ | View Details |